Decision support for eosinophilic esophagitis (EoE) patients
Part of Blood & lymphatic, Digestive system, Immune system & allergy clinical trials.
This study tests a decision aid (a simple tool) to help adults with EoE make choices about their care. You may be able to join if you are a new EoE patient at the University of Michigan, are 18 or older, speak English, and have internet access.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You have a new diagnosis of EoE (eosinophilic esophagitis) and are being seen at the University of Michigan
- You can speak and read English
- You have an email address and reliable internet access
- You are not currently in prison or living in a long-term care facility
- You do not have severe vision or memory problems that would make it hard to use a web-based tool
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an intervention meant to improve how well adults with eosinophilic esophagitis (EoE) follow their ongoing treatment plan. It may help you stay on your medicine and get better symptom control by making adherence easier.
This Phase 1/2 study tests EP-104GI in adults with eosinophilic esophagitis (EoE), a condition where certain immune cells cause inflammation in the food pipe. It may help improve symptoms and inflammation, and the study also includes a part where people who do well can switch to the active drug.
This is a registry (like a medical diary) for people with EoE who are getting regular treatment. It helps doctors track how EoE affects people over time, so they can improve care for everyone.
This study looks at how to improve care for people with eosinophilic esophagitis (EoE), a condition that causes inflammation in the esophagus. It may help you if you have or are being checked for EoE.
This study looks at how eosinophilic inflammation in the esophagus and intestines affects outcomes like symptoms and test findings. It may help clinicians better understand these conditions and track what changes over time.
This study tests whether a medication called upadacitinib can help people with eosinophilic esophagitis (a condition where too many white blood cells called eosinophils build up in the food tube) who are not getting better with their current steroid treatment. The medication works by reducing inflammation in the esophagus.
Hear when a new Eosinophilic Esophagitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.